Nuvo Group—the creators of INVU by Nuvo™, an FDA-approved remote pregnancy monitoring platform—announced today that it has completed the first phase of its collaboration agreement with Israel’s Sheba Medical Center’s “Sheba BEYOND”, one of the Top Ten medical centers in the world (NEWSWEEK) and a global leader in biotechnological innovation.
The first phase of the partnership consisted of a groundbreaking pilot program around gestational diabetes management, in which medically necessary non-stress tests (NSTs) were shifted to home-based, remote monitoring using INVU™ rather than conducting traditional monitoring in a medical facility. Participating physicians prescribed INVU to expectant mothers, who wore the sensor band from home during virtual visits. During these virtual visits anchored by the hospital’s Sheba BEYOND, virtual hospital platform, a live reading allowed the expectant mother to access simplified data and insights via the paired INVU app, while the provider received more detailed fetal and maternal surveillance that OB/GYNs are accustomed to receiving during in-office visits.
To provide a comprehensive virtualized care regimen, the pilot program also included the use of several other telemedicine solutions alongside INVU, including a remote ultrasound device, glucose monitoring, and home urinalysis kit. In addition to offering a safe and proven regimen for managing gestational diabetes, the program aimed to help patients and providers save time and ultimately improve the overall care experience.
For the next phase of the partnership, Nuvo and Sheba intend to work together to integrate the INVU platform into the hospital’s standard of care protocols. They also plan to utilize data collected from the pilot program to develop new AI tools with the goals of advancing pregnancy care management, improving outcomes, and lowering costs.
“Our long term goal is to provide pregnant women with the best possible maternal-fetal surveillance wherever they are – in our clinics, at the comfort of their home or during their work day,” said Dr. Avi Tsur, high-risk pregnancy expert and director of Sheba’s Women’s Health Innovation Center and Sheba BEYOND’s Obstetrics & Gynecology Beyond tele-health platform. “The INVU fetal monitoring solution has the potential to be a catalyst of transformative care in an area of medicine that has been lagging in innovation and new approaches for decades. I hope this pilot is only the beginning.”
Dr. Galia Barkai, Director of Sheba BEYOND added, “Sheba Beyond is constantly adopting cutting-edge technologies, which are enabling patients to receive the best care in the comfort of their homes. This collaboration is yet another step towards our goal to bring high level, hospital care, to everyone, everywhere.”
“It is an honor to collaborate with a leading medical center like Sheba to bring Nuvo’s INVU technology to expectant mothers in Israel,” said Kelly Londy, CEO of Nuvo Group. “The INVU platform is particularly beneficial for high-risk pregnancies that would otherwise require frequent in-office visits, which we know can become burdensome on all sides. We look forward to the next phase of our partnership as we continue to work with Sheba to help deliver safe and reliable remote care to even more patients.”
“Sheba aspires to be the institution that comes to mind when thinking about transformative healthcare,” Prof. Eyal Zimlichman, chief transformation officer and chief innovation officer at Sheba Medical Center maintained. “We do this by staying ahead of the curve when it comes to the latest and greatest advancements, as we know that transformation via innovation is the fastest path to material change. We’re excited about what this partnership with Nuvo can mean for the future of pregnancy care.”
Published August 17, PR Newswire